Search research articles
Contact Us
Filters
Showing results (31-40 of 114) with videos related to
Page
of 12
Sort By:
Clinical and Experimental Rheumatology
|
August 30, 2018
One year in review 2018: Sjögren's syndrome
Ourania D Argyropoulou, Eleonora Valentini, Francesco Ferro, et al.
Clinical and Experimental Rheumatology
|
March 25, 2020
COVID-19: the new challenge for rheumatologists
Francesco Ferro, Elena Elefante, Chiara Baldini, et al.
Clinical and Experimental Rheumatology
|
October 2, 2012
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome
Chiara Baldini, Chiara Notarstefano, Pasquale Pepe, et al.
Clinical and Experimental Rheumatology
|
December 25, 2018
Behçet's syndrome and psychiatric involvement: is it a primary or secondary feature of the disease?
Rosaria Talarico, Laura Palagini, Elena Elefante, et al.
Diagnostics (Basel, Switzerland)
|
September 9, 2023
UHFUS: A Valuable Tool in Evaluating Exocrine Gland Abnormalities in Sjögren's Disease
Giovanni Fulvio, Rossana Izzetti, Giacomo Aringhieri, et al.
Clinical and Experimental Rheumatology
|
November 8, 2019
Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation?
Marco Di Battista, Chiara Tani, Elena Elefante, et al.
Rheumatology International
|
October 8, 2013
Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes?
Chiara Baldini, Andrea Delle Sedie, Nicoletta Luciano, et al.
Clinical and Experimental Rheumatology
|
August 30, 2018
Imaging in primary Sjögren's syndrome: the 'obsolete and the new'
Chiara Baldini, Alen Zabotti, Nenad Filipovic, et al.
Arthritis Research & Therapy
|
October 15, 2020
Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus
Elena Elefante, Chiara Tani, Chiara Stagnaro, et al.
RMD Open
|
July 6, 2019
Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience
Chiara Tani, Elena Elefante, Viola Signorini, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 114) with videos related to
Sort By:
Page
of 12
Clinical and Experimental Rheumatology
|
August 30, 2018
One year in review 2018: Sjögren's syndrome
Ourania D Argyropoulou, Eleonora Valentini, Francesco Ferro, et al.
Clinical and Experimental Rheumatology
|
March 25, 2020
COVID-19: the new challenge for rheumatologists
Francesco Ferro, Elena Elefante, Chiara Baldini, et al.
Clinical and Experimental Rheumatology
|
October 2, 2012
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome
Chiara Baldini, Chiara Notarstefano, Pasquale Pepe, et al.
Clinical and Experimental Rheumatology
|
December 25, 2018
Behçet's syndrome and psychiatric involvement: is it a primary or secondary feature of the disease?
Rosaria Talarico, Laura Palagini, Elena Elefante, et al.
Diagnostics (Basel, Switzerland)
|
September 9, 2023
UHFUS: A Valuable Tool in Evaluating Exocrine Gland Abnormalities in Sjögren's Disease
Giovanni Fulvio, Rossana Izzetti, Giacomo Aringhieri, et al.
Clinical and Experimental Rheumatology
|
November 8, 2019
Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation?
Marco Di Battista, Chiara Tani, Elena Elefante, et al.
Rheumatology International
|
October 8, 2013
Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes?
Chiara Baldini, Andrea Delle Sedie, Nicoletta Luciano, et al.
Clinical and Experimental Rheumatology
|
August 30, 2018
Imaging in primary Sjögren's syndrome: the 'obsolete and the new'
Chiara Baldini, Alen Zabotti, Nenad Filipovic, et al.
Arthritis Research & Therapy
|
October 15, 2020
Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus
Elena Elefante, Chiara Tani, Chiara Stagnaro, et al.
RMD Open
|
July 6, 2019
Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience
Chiara Tani, Elena Elefante, Viola Signorini, et al.
Page
of 12